Keywords
Polycystic ovary sydrome
hiperandrogenism
anovulation
metabolic syndrome
hiperandrogenism
anovulation
metabolic syndrome
How to Cite
1.
Polycystic Ovarian Syndrome. Rev Med Clin [Internet]. 2018 May 31 [cited 2024 Dec. 25];2(2):74-85. Available from: https://mail.medicinaclinica.org/index.php/rmc/article/view/60
Abstract
Polycystic ovary syndrome is the most common endocrine disorder in women in reproductive age, and is characterized by the presence of hyperandrogenism with oligo/anovulation. The morphological change in the ovary could be present. In the present article the current classifications are discussed, as well as the physiopathological bases of the disease and its medical and general treatment, especially in relation to the presence of metabolic syndrome as a risk factor for cardio and cerebrovascular events
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2018 Journal of Clinical Medicine
Downloads
Download data is not yet available.